Skip to main content
. 2020 Jun 2;8(1):e000367. doi: 10.1136/jitc-2019-000367

Table 2.

Treatment-related adverse events in 32 patients

Treatment-related events Any grade Grade 1–2 Grade 3 Grade 4
Anemia 19 (59) 18 (56) 1 (3)
Neutropenia 26 (81) 19 (59) 6 (19) 1 (3)
Thrombocytopenia 20 (62) 2 (6) 7 (22) 11 (34)
Nausea 29 (91) 29 (91)
Vomit 4 (13) 4 (13)
Constipation 7 (22) 7 (22)
Fatigue 21 (66) 21 (66)
Rash 1 (3) 1 (3)
Fever 11 (34) 11 (34)
Elevated alanine aminotransferase 9 (28) 8 (25) 1 (3)
Elevated aspartate aminotransferase 9 (38) 8 (25) 1 (3)
Elevated amylase 1 (3) 1 (3)
Elevated lipase 2 (6) 1 (3) 1 (3)
Hyponatremia 1 (3) 1 (3)
Peripheral neuropathy 2 (6) 2 (6)
Hypertension 2 (6) 2 (6)

Data are n (%), unless otherwise specified.

No patients had fatal treatment-related adverse events.